MUSTANG BIO, INC. (MBIO) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $17.27M | +152.5% |
| 2024 | $6.84M | +9.7% |
| 2023 | $6.23M | -91.8% |
| 2022 | $75.66M | -31.0% |
| 2021 | $109.62M | +12.1% |
| 2020 | $97.80M | +59.3% |
| 2019 | $61.41M | +272.9% |
| 2018 | $16.47M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $17.27M | +152.5% |
| 2024 | $6.84M | +9.7% |
| 2023 | $6.23M | -91.8% |
| 2022 | $75.66M | -31.0% |
| 2021 | $109.62M | +12.1% |
| 2020 | $97.80M | +59.3% |
| 2019 | $61.41M | +272.9% |
| 2018 | $16.47M | — |